DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 684, Issue 1-2, 2010, Pages 43-48

  Sterpone, Silvia ^a   Cornetta, Tommaso ^a   Padua, Luca ^b   Mastellone, Valeria ^a   Giammarino, Daniela ^c   Testa, Antonella ^d   Tirindelli, Donatella ^d   Cozzi, Renata ^a   Donato, Vittorio ^c  

^a ROMA TRE UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d ENEA   (Italy)

Author keywords

Breast cancer; Comet assay; DNA repair; Gene polymorphisms; Radiotherapy

Indexed keywords

8 HYDROXYGUANINE DNA GLYCOSYLTRANSFERASE; ARGININE; BIOLOGICAL MARKER; CYSTEINE; DNA; DNA GLYCOSYLTRANSFERASE; GLYCINE; METHIONINE; SERINE; THREONINE; UNCLASSIFIED DRUG; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RADIOTHERAPY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; IONIZING RADIATION; ITALY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; SCORING SYSTEM; TISSUE INJURY;

ADULT; AGED; BREAST NEOPLASMS; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; ITALY; LYMPHOCYTES; MIDDLE AGED; POLYMORPHISM, GENETIC; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 73949140638     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.11.009     Document Type: Article

References (29)

1. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiological review. J. Natl. Cancer Inst. 91 (2000) 874-897
2. Setlow R.B. Variations in DNA repair among humans. In: Harris C.C., and Autrup H.N. (Eds). Human Carcinogenesis (1983), Academic Press, NewYork 231-254
3. Chang-Claude J., Popanda O., Tan X.L., Kropp S., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res. 11 13 (2005) 4802-4809
4. Andreassen C.N. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncol. 44 (2005) 801-815
5. Lehmann U., Hasemeier B., Christgen M., et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol. 214 1 (2008) 17-24
6. Hoffman A.E., Zheng T., Yi C., Leaderer D., et al. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69 14 (2009) 5970-5977
7. Bentzen S.M. Preventing or educing late side effects of radiation therapy: radiobiology meets molecular pathology. Nature 6 (2006) 702-713
8. Scott D., Barber J.B., Levine E.L., Burrill W., and Roberts S.A. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition?. Br. J. Cancer 77 4 (1998) 614-620
9. Popanda O., Marquardt J.U., Chang-Claude J., and Schmezer P. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat. Res. 667 1-2 (2009) 58-69
10. Bourguignon M.H., Gisone P.A., Perez M.R., et al. Genetic and epigenetic features in radiation sensitivity. Part I. Cell signalling in radiation response. Eur. J. Nucl. Med. Mol. Imag. 32 2 (2005) 229-246
11. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31 5 (1995) 1341-1346
12. Cornetta T., Festa F., Testa A., and Cozzi R. DNA damage repair and genetic polymorphisms: assessment of individual radiosensitivity and repair capacity. Int. J. Radiat. Oncol. Biol. Phys. 66 2 (2006) 537-545
13. Collins A.R. The Comet assay for DNA damage and repair: principles, application and limitations. Mol. Biotechnol. 26 (2004) 249-261
14. Tuimala J., Szekely G., Gundy S., Hievonen A., and Norppa H. Genetic polymorphisms of DNA repair and xenobiotics metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 32 (2002) 1003-1008
15. Shen M.R., Jones I.M., and Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58 4 (1998) 604-608
16. Takezaki T., Gao C.M., Wu J.Z., et al. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int. J. Cancer 99 4 (2002) 624-627
17. Smith T.R., Miller M.S., Lohman K.K., Case L.D., and Hu J.J. DNA damage and breast cancer risk. Carcinogenesis 24 5 (2003) 883-889
18. Shahidi M., Mozdarani H., and Bryant P.E. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay. Cancer Lett. 257 2 (2007) 263-273
19. Sánchez-Suárez P., Ostrosky-Wegman P., Gallegos-Hernández F., et al. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer. Mutat. Res. 640 1-2 (2008) 8-15
20. Synowiec E., Stefanska J., Morawiec Z., Blasiak J., and Wozniak K. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat. Res. 648 1-2 (2008) 65-72
21. Moullan N., Cox D.G., Angèle S., Romestaing P., Gérard J.P., and Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomark. Prev. 12 11 Pt 1 (2003) 1168-1174
22. Smith T.R., Miller M.S., Lohman K., et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 190 2 (2003) 183-190
23. Silva S.N., Moita R., Azevedo A.P., et al. Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect. Prev. 31 4 (2007) 303-309
24. Alapetite C., Thirion P., de la Rochefordière A., Cosset J.M., and Moustacchi E. Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int. J. Cancer 83 1 (1999) 83-90
25. Popanda O., Ebbeler R., Twardella D., et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 55 5 (2003) 1216-1225
26. Andreassen C.N., Alsner J., Overgaard M., and Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother. Oncol. 69 2 (2003) 127-135
27. Andreassen C.N., Alsner J., Overgaard J., et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother. Oncol. 75 1 (2005) 18-21
28. Azria D., Ozsahin M., Kramar A., et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin. Cancer Res. 14 19 (2008) 6284-6288
29. Huang Y., Li L., and Yu L. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24 4 (2009) 331-339